Project Grant T32HL176457
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $448K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $777,954 to the Icahn School of Medicine at Mount Sinai to conduct research on improving preconception cardiovascular health among adolescents. The key products and services to be delivered through this grant include: Constructing a school-based adolescent preconception cohort through data linkages to study the influence of school environments on cardiovascular risk...
- The Icahn School of Medicine at Mount Sinai received a $172,764 Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to study the relationship between the liver, metabolic syndrome, and increased cardiovascular disease risk among African American World Trade Center general responders. The award will support research and investigations focused on this public health topic over a 2-year period from July 1, 2025...
- This $420,834 Project Grant was awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to the Icahn School of Medicine at Mount Sinai. The grant will be used to elucidate the neural mechanisms connecting the brain and heart during stress, focusing on two key communication pathways: bottom-up (nodose ganglion to nucleus of the solitary tract) and top-down (nucleus ambiguus to the heart). The research aims...
- This Project Grant award of $331,270 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to the Icahn School of Medicine at Mount Sinai (ISMMS) on July 15, 2025. The award supports the Integrated Training in Pharmacological Sciences Program (ITPSP), a 5-year initiative aimed at developing highly skilled biomedical scientists to advance drug discovery research through rigorous and ethical...
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded a $816,472 project grant to the Icahn School of Medicine at Mount Sinai (ISMMS). The grant, awarded on August 1, 2025 and set to conclude on May 31, 2029, aims to enhance cardiovascular risk prediction and treatment response in obstructive sleep apnea (OSA) patients using advanced AI-based transformer models and multi-modal sleep data. The project will...
- This federal Project Grant award of $843,607, provided by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), supports research at the Icahn School of Medicine at Mount Sinai to investigate the link between ischemic cardiac injury and its impact on sleep regulation through an immune-mediated heart-brain axis. The research aims to document the neuroimmune pathways that regulate sleep after myocardial infarction (MI) and the consequential brain-heart outputs...
- The federal Project Grant award of $507,000.00 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to develop an automated system that integrates micro-electromechanical sensors, automation, and machine vision to simultaneously measure electrophysiological properties and contractile forces in single human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). This innovative system is expected to significantly reduce measurement time...
- This $1,807,897 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides funding to support the Medical Scientist Training Program (MSTP) at Stony Brook University. The MSTP aims to train physician-scientists by exposing students to both clinical and basic scientific activities throughout their MD-PhD training. The program has a 41-year history of producing graduates who have gone on...
- The Icahn School of Medicine at Mount Sinai (ISMMS) was awarded a $676,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "EPIGENETIC STUDIES OF CANDIDATE CELLS OF ORIGIN FOR DIFFUSE MIDLINE GLIOMA," is for a research project spanning from September 1, 2024, to August 31, 2026. The funding will support ISMMS's investigation into epigenetic factors that contribute to the development of diffuse...
- The Defense Health Agency awarded the Icahn School of Medicine at Mount Sinai a $3,300,817.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will leverage personalized stem cell therapy to overcome airway reconstruction challenges. The research will be conducted in New York, NY and is expected to be completed by May 31, 2029. The Icahn School of Medicine at Mount Sinai is a prominent academic medical center and research institution known for...